BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes
When BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...
Tag: BioNTech
Pfizer, BioNTech effort to develop Covid-flu combination shot sees setback
Pfizer and BioNTech said Friday that their combined mRNA vaccine candidate against influenza and Covid-19 showed a lower immune response ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!